Perampanel as First Adjunctive Treatment in Patients with Focal-Onset Seizures in the FAME Study: Post hoc Analyses of Dose-Related Efficacy, Safety and Clinical Factors Associated with Response
Dong Wook Kim, Ji Hyun Kim, Sang Kun Lee, Sang Ahm Lee, Ji Woong Lee, Min Young Kim, Dae-Won Seo
J Epilepsy Res. 2022;12(1):6-12. Published online 2022 Jun 30 DOI: https://doi.org/10.14581/jer.22002
Citations to this article as recorded by 
Perampanel as Add-on in Patients Aged ≥ 12 Years with Focal Epilepsy: A Prospective Real-World Observational Study from Southern China
Xiaoli Shi, Xiangru Lu, Lixia Li, Yanting Lu, Lang Shen, Jinou Zheng, Yuan Wu, Lu Yu
Neurology and Therapy.2025;[Epub] CrossRef
Investigation of efficacy, safety and tolerability of perampanel monotherapy in children with newly-diagnosed epilepsy in routine clinical practice in China: a multicenter prospective observational study
Tao-Yun Ji, Yi-Feng Ding, Yu-Qin Zhang, Li Jiang, Guo Zheng, Rong Luo, Dan Sun, Feng Gao, Yu-Wu Jiang, Yi Wang
World Journal of Pediatrics.2025;[Epub] CrossRef
Structural connectivity as a predictive factor for perampanel response in patients with epilepsy
Dong Ah Lee, Ho-Joon Lee, Kang Min Park
Seizure: European Journal of Epilepsy.2024; 118: 125. CrossRef